Tetrathiomolybdate [clinicaltrials_resource:972cd5a046044129b45e29f1fbbb8b74]
Study of Tetrathiomolybdate in Patients With Wilson Disease [clinicaltrials:NCT00004339]Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate [clinicaltrials:NCT00006332]A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris [clinicaltrials:NCT00113542]Tetrathiomolybdate in Hormone Refractory Prostate Cancer [clinicaltrials:NCT00150995]Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma [clinicaltrials:NCT00176774]Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma [clinicaltrials:NCT00176800]Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis [clinicaltrials:NCT00189176]Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer [clinicaltrials:NCT00195091]A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma [clinicaltrials:NCT00352742]Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma [clinicaltrials:NCT00383851]clinicaltrials:NCT00405574Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [clinicaltrials:NCT00560495]Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer [clinicaltrials:NCT00674557]Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis [clinicaltrials:NCT00805805]clinicaltrials:NCT01837329
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tetrathiomolybdate [clinicaltrials_resource:972cd5a046044129b45e29f1fbbb8b74]
Bio2RDF identifier
972cd5a046044129b45e29f1fbbb8b74
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:972cd5a046044129b45e29f1fbbb8b74
identifier
clinicaltrials_resource:972cd5a046044129b45e29f1fbbb8b74
title
Tetrathiomolybdate
@en
type
label
Tetrathiomolybdate [clinicaltrials_resource:972cd5a046044129b45e29f1fbbb8b74]
@en